Elucidating the cellular uptake mechanisms of heptamethine cyanine dye analogues for their use as an anticancer drug‐carrier molecule for the treatment of glioblastoma-Reference-Cited by-同舟云学术

Elucidating the cellular uptake mechanisms of heptamethine cyanine dye analogues for their use as an anticancer drug‐carrier molecule for the treatment of glioblastoma

Published:2022-11-29 Issue:3 Volume:101 Page:696-716
ISSN:1747-0277
Container-title:Chemical Biology & Drug Design
language:en
Short-container-title:Chem Biol Drug Des

Author:

Cooper Elizabeth¹²³⁴,Choi Peter J.³,Hwang Kihwan⁵,Nam Kyung M.⁵,Kim Chae‐Yong⁵,Shaban Tina³,Schweder Patrick⁵⁶,Mee Edward²⁶,Correia Jason²⁶,Turner Clinton²⁷,Faull Richard L. M.²,Denny William A.³,Noguchi Katsuya⁸,Dragunow Mike¹²⁴,Jose Jiney³,Park Thomas I.‐H.¹²⁴

Affiliation:

1. Department of Pharmacology University of Auckland Auckland New Zealand

2. Neurosurgical Research Unit, The Centre for Brain Research University of Auckland Auckland New Zealand

3. Auckland Cancer Society Research Centre School of Medical Sciences, University of Auckland Auckland New Zealand

4. The Hugh Green Biobank, The Centre for Brain Research University of Auckland Auckland New Zealand

5. Department of Neurosurgery Seoul National University Bundang Hospital, Seoul National University College of Medicine Seongnam Republic of Korea

6. Department of Neurosurgery Auckland City Hospital Auckland New Zealand

7. Department of Anatomical Pathology, Pathology and Laboratory Medicine Auckland City Hospital Auckland New Zealand

8. Dojindo Laboratories Co., Ltd Techno‐Research Park Kumamoto Japan

Funder

Neurological Foundation of New Zealand

Cancer Research Trust New Zealand

Cure Kids

Health Research Council of New Zealand

Hugh Green Foundation

Seoul National University

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cbdd.14171

Reference77 articles.

1. Distribution of Gefitinib to the Brain Is Limited by P-glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2)-Mediated Active Efflux

2. Exploiting Endocytosis for Nanomedicines

3. Nanoparticles in the clinic

4. Assessment of Glioblastoma Response in the Era of Bevacizumab: Longstanding and Emergent Challenges in the Imaging Evaluation of Pseudoresponse

5. Near-infrared fluorescence heptamethine carbocyanine dyes mediate imaging and targeted drug delivery for human brain tumor

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemogenic albumin-seeking NIR dyes for in vivo site-specific albumin tagging;Sensors and Actuators B: Chemical;2024-09

2. Involvement of the tumour necrosis factor receptor system in glioblastoma cell death induced by palbociclib-heptamethine cyanine dye conjugate;Cell Communication and Signaling;2024-01-11

3. Cyanine Dye Conjugation Enhances Crizotinib Localization to Intracranial Tumors, Attenuating NF-κB-Inducing Kinase Activity and Glioma Progression;Molecular Pharmaceutics;2023-11-08